2002
Integrating cancer genomics and proteomics in the post-genome era. Proteomics. 2002;2(1):69-75.
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.
Functional genomics and the breast cancer problem. Cancer Cell. 2002;1(1):15-7.
Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol. 2002;198(4):450-7.
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev. 2002;15(3):439-64.
Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74(9):1273-80.
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.
OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.
Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microsc Res Tech. 2002;59(2):85-91.
Progressive sclerosis of isolated foot metastasis of prostate cancer. J Urol. 2002;167(3):1392.